Navidea Biopharmaceuticals
Présence
Navidea Biopharmaceuticals est une société cotée sous le symbole boursier NAVB (US).
Dirigeants
Voir l'organigramme avec ses 7 principaux dirigeants
Biographies les plus recherchées chez Navidea Biopharmaceuticals
Changements de dirigeants chez Navidea Biopharmaceuticals
- Craig Dais, a rejoint l'entreprise comme Chief Financial Officer (publié le 28 juillet 2023).
Créer une alerte
pour suivre les mouvements de dirigeants chez Navidea Biopharmaceuticals.
Pharmacie
Navidea Biopharmaceuticals a 1 863 concurrents dont Pfizer (Etats—Unis), Sanofi (France) et Johnson & Johnson (Etats—Unis).
Actualités en fusion/acquisition en Pharmacie.
- AstraZeneca has announced the acquisition of Fusion Pharma (publié le 23 mars 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publié le 19 mars 2024).
- Frontier Medicines vient d'annoncer une levée de fonds de 80 millions de dollars. (publié le 27 février 2024).
Contacts en Pharmacie
Actualités
Derniers communiqués de presse par Navidea Biopharmaceuticals
- Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial Officer :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American Determination :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Press Releases :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps Down :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Navidea Biopharmaceuticals
- Navidea Biopharmaceuticals sur Wikipédia, Google News & Yahoo Finance en 1-click
- Navidea Biopharmaceuticals sur LinkedIn, Twitter & YouTube en 1-click
